In 2021, the global Neurology Clinical Trials Market was estimated to be worth approximately US$ 5.4 billion. With a predicted CAGR of 6.3% over the next ten years, the market is expected to be worth about US$ 10.5 billion by the end of 2032. The neurology clinical trials market is estimated to increase at a compound annual growth rate of 4.8 percent over the forecast period.
Get Full Access @...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek